Talking Medicines Pharmaceutical Technology Firm

Glasgow-based firm Talking Medicines aims for growth in 2021 with three senior appointments.

10:17 22 January 2021

Talking Medicines, a Glasgow-based pharmaceutical social intelligence company, has announced three senior appointments as it looks forward to securing Series A funding later this year. 

 

The firm's new head of product is Tatiana Nantes, who has 10 years of international product management experience at WMware. With her new role, she will focus on the delivery of social intelligence solutions for the pharmaceutical industry. 

 

Tom Lynch, on the other hand, is the firm's new senior engineer while Adrian Mursec has been hired as a front-end developer. 

 

Chief executive Jo Halliday said: “2021 is a huge year for Talking Medicines - having been in a deep R&D stage developing our AI offering, we are now in a great position to launch our platform to the pharma industry.

 

"Tatiana, Tom and Adrian will all provide invaluable expertise and experience as we embark on this next phase of growth with a view to securing Series A funding later this year.”